首页> 美国卫生研究院文献>ISRN Urology >Antioncogenic Effects of Transient Receptor Potential Vanilloid 1 in the Progression of Transitional Urothelial Cancer of Human Bladder
【2h】

Antioncogenic Effects of Transient Receptor Potential Vanilloid 1 in the Progression of Transitional Urothelial Cancer of Human Bladder

机译:瞬态受体电位香草醛1在人膀胱移行性尿路上皮癌进展中的抗癌作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The progression of normal cells to a tumorigenic and metastatic state involves the accumulation of mutations in multiple key signaling proteins, encoded by oncogenes and tumor suppressor genes. Recently, members of the TRP channel family have been included in the oncogenic and tumor suppressor protein family. TRPM1, TRPM8, and TRPV6 are considered to be tumor suppressors and oncogenes in localized melanoma and prostate cancer, respectively. Herein, we focus our attention on the antioncogenic properties of TRPV1. Changes in TRPV1 expression occur during the development of transitional cell carcinoma (TCC) of human bladder. A progressive decrease in TRPV1 expression as the TCC stage increases triggers the development of a more aggressive gene phenotype and invasiveness. Finally, downregulation of TRPV1 represents a negative prognostic factor in TCC patients. The knowledge of the mechanism controlling TRPV1 expression might improve the diagnosis and new therapeutic strategies in bladder cancer.
机译:正常细胞向致瘤和转移状态的进展涉及由癌基因和肿瘤抑制基因编码的多种关键信号蛋白中突变的积累。最近,TRP通道家族的成员已包括在致癌和抑癌蛋白家族中。 TRPM1,TRPM8和TRPV6分别被认为是局部黑色素瘤和前列腺癌的抑癌基因和癌基因。在此,我们将注意力集中在TRPV1的抗癌特性上。 TRPV1表达的变化发生在人类膀胱移行细胞癌(TCC)的发展过程中。随着TCC阶段的增加,TRPV1表达的逐渐降低触发了更具攻击性的基因表型和侵袭性的发展。最后,TRPV1的下调代表TCC患者的阴性预后因素。控制TRPV1表达机制的知识可能会改善膀胱癌的诊断和新的治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号